Showing 1351-1360 of 3020 results for "".
- Novartis Offers Free Genetic Testing for Advanced Melanomahttps://practicaldermatology.com/news/novartis-offers-free-genetic-testing-for-advanced-melanoma/2460095/The Know Now Testing Program is an initiative from Novartis in collaboration with Quest Diagnostics that offers genetic mutation testing at no cost for all patients with stage III or stage IV melanoma. Nearly half of all advanced melanoma patients carry a specific mutation, called BRAF.
- New to SENTE BOD: Clint Carnell and Clement Gingrashttps://practicaldermatology.com/news/new-to-sente-bod-clint-carnell-and-clement-gingras/2460093/SENTÉ has appointed Clint Carnell and Clement Gingras to its Board of Directors effective immediately. "We are thrilled to have both Clint and Clement join the SENTÉ team," says Faheem Hasnain, Chairman of t
- Sonrei Sea Clearly Gel Sunscreens Launchhttps://practicaldermatology.com/news/sonrei-sea-clearly-gel-sunscreens-launch/2460070/A new eco-friendly, gel-based sunscreen line from Sonrei, LLC is now available. “Crafted for every kind,” Sonrei is driven by a commitment of bringing to market a translucent broad-spectrum SPF with environmental principles at the core, the company says. Sonrei Sea Clearly T
- Gillette Skin Guard Reduces Razor Bumps by 60%https://practicaldermatology.com/news/gillette-skin-guard-reduces-razor-bumps-by-60/2460065/Gillette’s recently launched SkinGuard razor is helping men who are susceptible to razor bumps, also known as Pseudofolliculitis barbae or PFB, new research shows. Results from a recent clinical study from Wake Forest University revealed that the incidence of men’
- Study: Indoor Tanning Addiction May Be Abetted by Genetic and Psychiatric Factorshttps://practicaldermatology.com/news/study-indoor-tanning-addiction-may-be-abetted-by-genetic-and-psychiatric-factors/2460059/A combination of elevated symptoms of depression along with modifications in a gene responsible for dopamine activity appear to influence an addiction to indoor tanning in young, white non-Hispanic women, a new study suggests. The findings appear in the Annals of Behaviora
- Galderma Partners with Three Charitieshttps://practicaldermatology.com/news/galderma-partners-with-three-charities/2460047/Galderma is partnering with
- Study: Teen Acne Linked to Better Gradeshttps://practicaldermatology.com/news/study-teen-acne-linked-to-better-grades/2460038/Individuals who had acne during their teen years earned higher grades in high school and were more likely to complete their bachelor’s degrees, according to a new study in the Journal of Human Capital.
- Good Science Beauty Skincare Line Makes NYC Debuthttps://practicaldermatology.com/news/good-science-beauty-skincare-line-makes-nyc-debut/2460028/Spring always heralds the arrival many new skincare lines and products, and one of this season’s standouts may be Good Science Beauty, a line of six collagen-boosting products delivered via Silicon+ technology. The new skincare line was
- Crown Labs Adds to Portfolio with Acquisition of Keri from GSKhttps://practicaldermatology.com/news/crown-labs-adds-to-portfolio-with-acquisition-of-keri-from-gsk/2460017/Crown Laboratories, Inc. acquired the North American rights for Keri from GlaxoSmithKline (GSK). The acquisition of Keri from GSK marks the sixth product from GSK that Crown has acquired in the past five months. “Acqui
- Fibrocell to Collaborate with Castle Creek Pharmaceuticals to Develop and Commercialize RDEB Gene Therapyhttps://practicaldermatology.com/news/fibrocell-to-collaborate-with-castle-creek-pharmaceuticals-to-develop-and-commercialize-rdeb-gene-therapy/2460004/Fibrocell Science, Inc. has entered into a collaboration agreement with Castle Creek Pharmaceuticals to develop and commercialize Fibrocell’s lead gene therapy candidate, FCX-007, for the treatment of recessive dystrophic epidermolysis bullosa (RDEB), a rare, life-threatening genetic disord